By observing its effects both in vivo (on mouse stroke models) and in vitro (on cell cultures), they came to the conclusion that Tetramethylpyrazine, by lowering ET-1 expression in astrocytes, therefore inhibits ROS and oxidative stress during cerebral ischemia and attenuates blood–brain barrier damage [48]. This evidence concerns the gene EDN1 and Stroke.